The people leading MDGH’s mission
MDGH has assembled a highly experienced leadership team, a seasoned board of directors and a group of distinguished scientific advisors to develop and deliver new medicines for neglected diseases. Our experienced and dedicated team works collaboratively and effectively to achieve global health equity.
Managing Director
Head of Development Management
Global Head of Regulatory Affairs
Chief Operating Officer
Vice President, Project Leader Onchocerciasis
Chair of the Board
Lorna is currently Vice President, Commercial Operations, Asia Pacific of Seqirus bioCSL Ltd., (A CSL company). She has enjoyed a successful 25-year career in the pharmaceutical industry, encompassing clinical research, business development, marketing, and sales across a wide variety of therapeutic areas, including respiratory, CNS, cardiopulmonary, oncology, metabolic, psychiatry, neurology, HIV, pain, and vaccines. Lorna previously worked for GSK Australia as Commercial Vice President, before establishing Ikaria Australia Pty Ltd., a biotherapeutics company that commercialised drugs and devices for intensive care medicine. She was a director and secretary of BioMelbourne Network (an industry-led membership association for organisations engaged in biotechnology, medical technology, and health innovation in the state of Victoria). Lorna graduated with a PhD in Neurobiology (University College London) and a BSc in Pharmacology (University of Glasgow), and went on to hold academic positions at the Cardiothoracic Institute at the Royal Brompton Hospital (London) and the Royal Postgraduate Medical School (London).
Chair of the Board
Managing Director
Mark Sullivan is MDGH’s founder and managing director. He was previously a clinical programme head at GSK in London; Associate Director, Clinical at Gilead Sciences in California; and Chief Operating Officer of Australia’s vaccine design and development consortium at the University of New South Wales. He has contributed to three successful global registrational programs for HIV and hepatitis B therapeutics, has worked on 40 small molecule and biologic development programs at all stages, and led the development of moxidectin through FDA approval. Mark was the 2019 Victorian Australian of the Year.
Managing Director
Director
Andrew Wilks, BSc, PhD, was most recently Chief Scientific Officer and founder of Cytopia. Prior to starting Cytopia, Andrew was at the Ludwig Institute for Cancer Research in Melbourne where he discovered the JAK kinases. He holds an Honorary Professorship at Monash University (Melbourne) and was the inaugural winner of the Australian Biobusiness Award in 2007. Based in Melbourne, Australia, Andrew co-founded SYN|thesis in 2007 and now oversees global operations.
Director
Director
Richard has over 25 years’ experience in negotiating and documenting commercial arrangements and is highly regarded for his expertise in advising clients on all aspects of commercial transactions and corporate issues. Richard was a founding partner of the Banki Haddock Fiora partnership in 1995. His clients include research organisations and universities, statutory corporations, educators, primary industry bodies, publishers, and media operators.
Director
Company Secretary
Daren is a corporate, commercial and finance lawyer with over 30 years’ experience in leading and quality law firms, advising clients on significant, complex, transactional, regulatory and governance matters. His clients include and have included ASX-listed public companies, private concerns, leading universities and schools, other not-for-profit companies and peak bodies, including technology-rich, emerging, creative industry and pharmaceutical ventures. He is a Fellow of the Australian Institute of Company Directors and an ANU College of Law Graduate of Distinction.
Company Secretary
Chief Development Officer at Pardes Biosciences
Vice President for Medical Affairs at ADC Therapeutics
Senior Vice President Drug Development Science, Integrated Drug Development at Certara
Principal at Linus Consulting, LLC
Principal at GL Fisher Consulting, LLC
MBBS, PhD